The global Cancer Biomarkers market is
expected to reach $XX billion by 2023 from $XX billion in 2017 growing at a
CAGR of XX%. Biomarkers are the molecules which indicate normal or abnormal
processes taking place in the body. Cancer biomarkers can be DNA, mRNA,
proteins, metabolites, or processes such as apoptosis, ang..